South Africa: 'Someone Had to Do It', Says SA TB Activist On Time 100 List
[spotlight] Phumeza Tisile from Khayelitsha was 19 years old when she contracted multidrug-resistant tuberculosis (MDR-TB). She battled the disease for nearly four years, then lost her hearing as a side effect from the cocktail of drugs used to treat the TB. At one stage, a doctor told her to visit a priest and prepare her soul for death. (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - November 23, 2023 Category: Infectious Diseases Tags: Health and Medicine South Africa Southern Africa Sustainable Development Tuberculosis Source Type: news
Strain of Multidrug-Resistant Salmonella Newport Remains Linked to Travel to Mexico and U.S. Beef Products - United States, 2021-2022
This report describes increases in human infections with a strain of multidrug-resistant Salmonella linked to travel to Mexico and U.S. beef products. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - November 9, 2023 Category: American Health Tags: Antibiotic and Antimicrobial Resistance MMWR Morbidity & Mortality Weekly Report Outbreaks Salmonella Source Type: news
Fecal Transplants in Kidney Recipients Reduced Resistant Pathogens
(MedPage Today) -- In the single-center PREMIX clinical trial, most renal transplant recipients were negative for multidrug-resistant pathogens shortly after receiving fecal microbiota transplants (FMT), with longer times to recurrent infections... (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - November 2, 2023 Category: Infectious Diseases Source Type: news
Africa: Breakthrough Promises Improved Access to TB Treatment Across Africa
[allAfrica] Cape Town -- An American drug manufacturer has taken an important step to open the way to improved access to the treatment of multidrug-resistant tuberculosis (MDR-TB) across Africa. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 1, 2023 Category: African Health Tags: Africa Economy, Business and Finance Company News External Relations Health and Medicine South Africa Southern Africa Tuberculosis United States, Canada and Africa Source Type: news
Africa: U.S. Drug Company Eases Access to Multidrug-Resistant Tuberculosis Treatment
[JNJ] Company continues to be focused on addressing perceived barriers to access and refocusing global efforts on the most-pressing barrier to access: underdiagnosis of the disease. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 1, 2023 Category: African Health Tags: Africa Economy, Business and Finance Company News External Relations Health and Medicine Tuberculosis United States, Canada and Africa Source Type: news
Tuberculosis Could Be the Next Global Health Crisis. Is the World Ready?
For those living in affluent countries, it’s easy to forget about tuberculosis, which seems like a disease of the Victorian era. In the U.S., thanks to investments in public health and TB surveillance infrastructure, less than 600 people died from the disease in 2020. Compared to COVID-19, which caused 350,000 deaths that same year, it’s understandable why it’s not at the top of the U.S. public health agenda.
[time-brightcove not-tgx=”true”]
But if you zoom out and look at global public health, TB gets much more scary. It is the world’s most deadly infectious disease, killing approx...
Source: TIME: Health - September 26, 2023 Category: Consumer Health News Authors: Anna Gordon Tags: Uncategorized Health Care Source Type: news
New Antibiotic Could Combat Multidrug-Resistant Superbugs New Antibiotic Could Combat Multidrug-Resistant Superbugs
The antibiotic acts on not one but three molecules that are essential to the construction of bacterial walls.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - September 15, 2023 Category: Allergy & Immunology Tags: Infectious Diseases News Source Type: news
NIH investigates multidrug-resistant bacterium emerging in community settings
Researchers study confluence of multidrug resistance and hypervirulence among Klebsiella pneumoniae. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - September 6, 2023 Category: American Health Source Type: news
CDC Details Multidrug-Resistant TB Outbreak in an Unlikely Spot
(MedPage Today) -- An outbreak of multidrug-resistant tuberculosis (TB) developed in Kansas in November 2021, and included multiple children who were born in the U.S. and became infected in the state, CDC researchers reported.
The outbreak involved... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - September 1, 2023 Category: American Health Source Type: news
Outbreak of Multidrug-Resistant Tuberculosis - Kansas, 2021-2022
This report describes a multidrug-resistant tuberculosis outbreak in Kansas. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - August 31, 2023 Category: American Health Tags: Latent Tuberculosis Infection - LTBI MMWR Morbidity & Mortality Weekly Report Multidrug-Resistant TB (MDR TB) Outbreaks Treatment Source Type: news
Venatorx Pharmaceuticals Announces FDA Acceptance and Priority Review of New Drug Application for Cefepime-Taniborbactam to Treat Complicated Urinary Tract Infections (cUTI), including Pyelonephritis, in Adults
Cefepime-taniborbactam has also demonstrated in vitro activity against CDC Urgent and Serious Threat Pathogens carbapenem-resistant Enterobacterales, multidrug-resistant Pseudomonas aeruginosa and Extended Spectrum Beta-lactamase-producing... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - August 15, 2023 Category: Drugs & Pharmacology Source Type: news
Africa: What's New in the TB Section of the 2023 WHO Model Lists of Essential Medicines
[WHO] The World Health Organization's (WHO's) 2023 Model Lists of Essential Medicines, published in July 2023, features key updates to the tuberculosis (TB) section. These complement current WHO recommendations for shorter treatment of multidrug-/rifampicin-resistant TB (MDR/RR-TB) and newer options to treat drug-susceptible TB in children and adolescents. WHO's Global Tuberculosis Programme, with inputs from partners, proposed these changes to the EML based on the latest WHO recommendations and the current avai (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - August 10, 2023 Category: Infectious Diseases Tags: Africa External Relations Health and Medicine International Organizations and Africa Tuberculosis Source Type: news
ICU Sink the Culprit in Hospital Superbug Cluster
(MedPage Today) -- Public health investigators linked two cases of multidrug-resistant bacterial infections in hospitalized patients to their most likely source -- a sink in the intensive care unit (ICU) room where both had stayed 4 months apart... (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - August 4, 2023 Category: Infectious Diseases Source Type: news
This fish delivers a nasty sting. Could it also save lives?
Ocean-goers along the Pacific Northwest’s rugged shorelines know to give the prickly Korean rockfish a wide berth. A type of scorpionfish, it can deliver a toxic strike with its spines. But according to a new study, the fish may possess the ability to heal as well as harm. A protein it produces can kill drug-resistant bacteria, the authors say, and could one day be used to treat infections in people with cystic fibrosis.
The discovery “sets the stage” for scientists to develop better tools to combat antibiotic resistance, says Nicole Iovine, an infectious disease expert at the University of Florida who was not ...
Source: ScienceNOW - July 24, 2023 Category: Science Source Type: news
How an Innovative Deal Will Give Millions Access to Cheaper Tuberculosis Drugs
The patent on the tuberculosis drug bedaquiline expires today (July 18). But while its manufacturer, Johnson & Johnson, intends to use secondary patents to extend its exclusive right to sell the drug, an innovative deal will lower its price and expand access to millions around the globe.
The drug improves the outcomes for patients with multidrug-resistant tuberculosis, reducing the risk of death by approximately 10%, according to a study in BMC Infectious Diseases, a U.K. medical journal. Tuberculosis is the world’s deadliest infectious disease, infecting approximately 10 million people per year and killing 1.5 ...
Source: TIME: Health - July 18, 2023 Category: Consumer Health News Authors: Anna Gordon Tags: Uncategorized Disease News Source Type: news
